Hormone Replacement Therapy (HRT) is the administration of hormones for replenishing those patients whose natural hormones are declining in their body. For example, it is prescribed to patient with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones. During menopause, with the falling estrogen levels, hormone replacement therapy is considered to be the most effective treatment for menopause symptoms. .

HORMONE REPLACEMENT THERAPY MARKET DYNAMICS 

The increasing incidences of hormonal imbalance disorders and coupled with elderly population are the primary drivers of this market. With various types of hormonal changes, the female body mostly gets affected by the natural process of aging, leading to abnormalities and diseases. According to the American Society for Reproductive Medicine, the menopause window in approach to the age group of 45 to 59, and average age for menopause is 51. Thus, adding to the demand in the global hormone replacement therapy market. As indicated by the American Congress of Obstetricians and Gynecologists, approximately 6,000 women reach menopause on a daily basis, in the country of the U.S. alone.

Get Free Sample Report for More Industry Insights: https://www.axiommrc.com/buy_now/10067-hormone-replacement-therapy

HORMONE REPLACEMENT THERAPY MARKET SEGMENTAL HIGHLIGHTS

The report analyses the global hormone replacement therapy market based therapy, route of administration, disease and geography.

HORMONE REPLACEMENT THERAPY MARKET BY THERAPY 

The various types of hormone replacement therapy are categorised into estrogen, human growth, thyroid and testosterone replacement therapy. The estrogen hormone replacement therapy is likely to observe the largest number of prescriptions as this therapy is used in women during post-menopause or hysterectomy and helps them maintain the hormonal balance. 

Moreover, the hormone growth replacement therapy is likely to observe significant growth owing to the rising incidences of growth deficiencies, particularly in infants. According to WHO, an estimated 15 million babies are born preterm and this number is rising and approximately 85% of these infants are not fully developed. Thus, the demand of the HRT is increasing.

HORMONE REPLACEMENT THERAPY MARKET BY ROUTE OF ADMINISTRATION 

The hormone replacement therapy can be administrated through various routes such as oral, parenteral, and transdermal. Oral medication is the most common form of hormone replacement therapy. Examples are conjugated Estrogens (Premarin), estradiol (Estrace), and Estratab.

HORMONE REPLACEMENT THERAPY MARKET BY DISEASE 

The hormone replacement therapy is used to treat various diseases such as menopause, hypothyroidism, male hypogonadism, growth hormone deficiency etc. The menopause segment is likely to account for the largest market share. Rapidly increasing population of geriatric women leads to increase in the number of women with menopausal symptoms. According to the United Nations World Population Aging Report -2017, women accounted for 54% share of the global population aged 60 years or above and 61% of that aged 80 years or above in 2017. The use of hormone replacement therapy alleviates menopausal symptoms and lead to a major improvement in quality of life for women with menopausal symptoms.

HORMONE REPLACEMENT THERAPY MARKET BY GEOGRAPHY

Based on geography, the global Hormone Replacement Therapy market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America accounted for the largest market share owing to the growing baby boomer population, high health care expenditure, and large number of prescriptions of hormonal treatment products.

HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS 

Key players in the global hormone replacement therapy market include Abbott Laboratories, Novartis AG, Pfizer Inc., Mylan Laboratories, Merck Co., Novo Nordisk AS, Bayer AG, Eli Lilly and Company, Genentech, F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co. Inc., Allergan, Noven Pharmaceuticals, Orion Pharma, Therapeutics MD, Endo Pharmaceuticals Inc, and Teva Pharmaceutical Industries Ltd among others 

Request For Best Pricing :- https://www.axiommrc.com/buy_now/10067-hormone-replacement-therapy

 About Us:

Axiom Market Research Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research Consulting™ aims to become the preferred market research and data Analytics Company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: [email protected]

Website: https://www.axiommrc.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter: https://twitter.com/AxiommrcCom